383 related articles for article (PubMed ID: 33386081)
1. Network machine learning maps phytochemically rich "Hyperfoods" to fight COVID-19.
Laponogov I; Gonzalez G; Shepherd M; Qureshi A; Veselkov D; Charkoftaki G; Vasiliou V; Youssef J; Mirnezami R; Bronstein M; Veselkov K
Hum Genomics; 2021 Jan; 15(1):1. PubMed ID: 33386081
[TBL] [Abstract][Full Text] [Related]
2. HyperFoods: Machine intelligent mapping of cancer-beating molecules in foods.
Veselkov K; Gonzalez G; Aljifri S; Galea D; Mirnezami R; Youssef J; Bronstein M; Laponogov I
Sci Rep; 2019 Jul; 9(1):9237. PubMed ID: 31270435
[TBL] [Abstract][Full Text] [Related]
3. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
Verma AK; Aggarwal R
Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
[TBL] [Abstract][Full Text] [Related]
4. Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation.
Nayarisseri A; Khandelwal R; Madhavi M; Selvaraj C; Panwar U; Sharma K; Hussain T; Singh SK
Curr Top Med Chem; 2020; 20(24):2146-2167. PubMed ID: 32621718
[TBL] [Abstract][Full Text] [Related]
5. Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins.
Dey L; Chakraborty S; Mukhopadhyay A
Biomed J; 2020 Oct; 43(5):438-450. PubMed ID: 33036956
[TBL] [Abstract][Full Text] [Related]
6. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.
Das G; Das T; Chowdhury N; Chatterjee D; Bagchi A; Ghosh Z
Genomics; 2021 Jan; 113(1 Pt 2):1129-1140. PubMed ID: 33189776
[TBL] [Abstract][Full Text] [Related]
7. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
8. Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2.
Kumar A; Loharch S; Kumar S; Ringe RP; Parkesh R
Comput Struct Biotechnol J; 2021; 19():424-438. PubMed ID: 33391634
[TBL] [Abstract][Full Text] [Related]
9. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
Anwaar MU; Adnan F; Abro A; Khan RA; Rehman AU; Osama M; Rainville C; Kumar S; Sterner DE; Javed S; Jamal SB; Baig A; Shabbir MR; Ahsan W; Butt TR; Assir MZ
Comput Biol Med; 2022 Feb; 141():105049. PubMed ID: 34823857
[TBL] [Abstract][Full Text] [Related]
10. In Silico Identification of Anti-SARS-CoV-2 Medicinal Plants Using Cheminformatics and Machine Learning.
Liang J; Zheng Y; Tong X; Yang N; Dai S
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615401
[TBL] [Abstract][Full Text] [Related]
11. Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment.
Liu J; Xu L; Guo W; Li Z; Khan MKH; Ge W; Patterson TA; Hong H
Exp Biol Med (Maywood); 2023 Nov; 248(21):1927-1936. PubMed ID: 37997891
[TBL] [Abstract][Full Text] [Related]
12. Advances in the computational landscape for repurposed drugs against COVID-19.
Aronskyy I; Masoudi-Sobhanzadeh Y; Cappuccio A; Zaslavsky E
Drug Discov Today; 2021 Dec; 26(12):2800-2815. PubMed ID: 34339864
[TBL] [Abstract][Full Text] [Related]
13. A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods.
Cihan P; Ozger ZB
Comput Biol Chem; 2022 Jun; 98():107688. PubMed ID: 35561658
[TBL] [Abstract][Full Text] [Related]
14. In Silico Screening of Natural Flavonoids against 3-Chymotrypsin-like Protease of SARS-CoV-2 Using Machine Learning and Molecular Modeling.
Cai L; Han F; Ji B; He X; Wang L; Niu T; Zhai J; Wang J
Molecules; 2023 Dec; 28(24):. PubMed ID: 38138524
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.
Kadioglu O; Saeed M; Greten HJ; Efferth T
Comput Biol Med; 2021 Jun; 133():104359. PubMed ID: 33845270
[TBL] [Abstract][Full Text] [Related]
16. Machine Learning Models Identify Inhibitors of SARS-CoV-2.
Gawriljuk VO; Zin PPK; Puhl AC; Zorn KM; Foil DH; Lane TR; Hurst B; Tavella TA; Costa FTM; Lakshmanane P; Bernatchez J; Godoy AS; Oliva G; Siqueira-Neto JL; Madrid PB; Ekins S
J Chem Inf Model; 2021 Sep; 61(9):4224-4235. PubMed ID: 34387990
[TBL] [Abstract][Full Text] [Related]
17. Efficient machine learning model for predicting drug-target interactions with case study for Covid-19.
El-Behery H; Attia AF; El-Feshawy N; Torkey H
Comput Biol Chem; 2021 Aug; 93():107536. PubMed ID: 34271420
[TBL] [Abstract][Full Text] [Related]
18. Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking.
Karki N; Verma N; Trozzi F; Tao P; Kraka E; Zoltowski B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557253
[TBL] [Abstract][Full Text] [Related]
19. Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches.
Ashraf FB; Akter S; Mumu SH; Islam MU; Uddin J
PLoS One; 2023; 18(9):e0288053. PubMed ID: 37669264
[TBL] [Abstract][Full Text] [Related]
20. Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases.
Kumari M; Subbarao N
Comput Biol Med; 2021 May; 132():104317. PubMed ID: 33721736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
